Genetic risk factors assessed for PE and DVT
. | Study design and N . | Country where study was conducted . | Age, y, mean (SD) . | PE (95% CI) . | DVT (95% CI) . | DVT + PE (95% CI) . |
---|---|---|---|---|---|---|
Blood group | Case-control | United States | Mean (SD) | |||
Ohira (2007)65 | N total = 1500 | 63(10) total | ||||
Non-O vs O | N cases = 492 | 63(10) cases | OR = 2.0 (1.4-2.9)* | OR = 1.4 (1.1-1.8)* | — | |
Lijfering (unpublished data) | Case-control | The Netherlands | 48, 18-72 | OR = 1.7 (1.4-1.9)† | OR = 2.3 (2.0-2.6)† | OR = 2.4 (1.8-3.2)† |
N total = 5317 | ||||||
N cases = 2377 | ||||||
FVL | Case-control | The Netherlands | Mean | OR = 1.7 (1.3-2.2) | OR = 4.5 (3.8-5.2) | — |
Van Stralen (2008)3 | N total = 8170 | 48 total | ||||
N cases = 3313 | 49 cases | |||||
De Moerloose (2000)11 | Case-control | Switzerland | 62 (19-99)* | OR = 2.1 (0.68-5.5) | OR = 3.4 (1.5-6.9) | OR = 4.2 (1.5-10.3) |
N total = 748 | ||||||
N cases = 3513 | ||||||
Margaglione (2000)10 | Case-control | Italy | Median, range | OR = 1.5 (0.74-3.1)‡ | OR = 6.3 (4.5-9.0)‡ | OR = 4.4 (2.8-7.0)‡ |
N total = 1976 | 46 (18-86) cases | |||||
N cases = 647 | 37 (22-66) controls | |||||
Manten (1996)4 | Case-control | The Netherlands | Mean | OR = 3.3 (1.0-10.6)† | OR = 6.9 (3.6-12.8)† | — |
N total = 753 | 42 cases | |||||
N cases = 279 | 44 controls | |||||
Martinelli (1997)7 | Case-control | Italy | Median (range) | OR = 1.8 (0.3-9.6)† | OR = 10.0 (4.0-25.5)† | OR = 5.5 (2.0-15.8)† |
N total = 424 | 37 (15-67) total | |||||
N cases = 212 | 35 (15-66) cases | |||||
Baglin (1997)6 | Case-control | United Kingdom | — | OR = 4.8 (2.5-9.2)§ | OR = 8.5 (4.8-14.8)§ | — |
N total = 1189 | ||||||
N cases = 678 | ||||||
Arsov (2006)5 | Case-control | Macedonia | — | OR = 2.6 (0.9-7.6) | OR = 5.3 (2.6-10.8) | — |
N total = 390 | ||||||
N cases = 190 | ||||||
Boyanovsky (2001)9 | Case-control | Bulgaria | Mean (range) | OR = 1.4 (0.45-4.6)‖ | OR = 5.1 (2.0-12.7)‖ | OR = 3.9 (1.5-10.2)‖ |
N total = 228 | 45 (21-68) cases | |||||
N cases = 128 | ||||||
González Ordóñez (2000)8 | Case-control | Spain | Mean (range) | OR = 1.3 (0.3-4.7) | OR = 6.6 (3.1-14.1) | OR = 5.2 (1.3-20.4) |
N total = 584 | 57 (17-93) cases | |||||
N cases = 264 | ||||||
Okumus (2008)68 | Case-control | Turkey | Mean, range | OR = 1.8 (0.82-4.0)¶ | OR = 3.8 (1.6-9.1)¶ | OR = 4.3 (2.1-8.8)¶ |
N total = 382 | 53 (16-88) cases | |||||
N cases = 191 | 51 (16-88) controls | |||||
Prothrombin G20210A | Case-control | The Netherlands | Mean | OR = 2.3 (1.5-3.3) | OR = 3.2 (2.4-4.2) | — |
Van Stralen (2008)3 | N total = 8170 | 48 total | ||||
N cases = 3313 | 49 cases | |||||
Margaglione (2000)10 | Case-control | Italy | Median, range | OR = 2.1 (1.1-4.1)‡ | OR = 3.6 (2.4-5.4)‡ | OR = 3.0 (1.8-5.1)‡ |
N total = 1976 | 46 (18-86) cases | |||||
N cases = 647 | 37 (22-66) controls | |||||
Boyanovsky (2001)9 | Case-control | Bulgaria | Mean (range) | OR = 1.5 (0.41-5.3)‖ | OR = 3.3 (1.1-9.6)‖ | OR = 3.0 (1.0-9.0)‖ |
N total = 228 | 45 (21-68) cases | |||||
N cases = 128 | ||||||
González Ordóñez (2000)8 | Case-control | Spain | Mean (range) | OR = 2.4 (0.9-6.1) | OR = 2.5 (1.1-5.4) | OR = 5.6 (1.6-18.9) |
N total = 584 | 57 (17-93) cases | |||||
N cases = 264 | ||||||
Okumus (2008)68 | Case-control | Turkey | Mean, range | OR = 1.6 (0.45-5.9)¶ | OR = 0.86 (0.10-7.3)¶ | OR = 3.7 (1.3-11.2)¶ |
N total = 382 | 53 (16-88) cases | |||||
N cases = 191 | 51(16-88) controls | |||||
De Moerloose (2000)11 | Case-control | Switzerland | 62 (19-99)* | OR = 0.90 (0.10-3.8) | OR = 0.61 (0.07-2.7) | OR = 2.6 (0.62-8.2) |
N total = 748 | ||||||
N cases = 182 | ||||||
Weischer (2010)69 | Cohort | Denmark | Median, IQR | HR = 1.7 (0.6-4.5)* | HR = 0.8 (0.3-2.5)* | — |
N total = 9231 | 52 (45-57) | |||||
for all VT patients |
. | Study design and N . | Country where study was conducted . | Age, y, mean (SD) . | PE (95% CI) . | DVT (95% CI) . | DVT + PE (95% CI) . |
---|---|---|---|---|---|---|
Blood group | Case-control | United States | Mean (SD) | |||
Ohira (2007)65 | N total = 1500 | 63(10) total | ||||
Non-O vs O | N cases = 492 | 63(10) cases | OR = 2.0 (1.4-2.9)* | OR = 1.4 (1.1-1.8)* | — | |
Lijfering (unpublished data) | Case-control | The Netherlands | 48, 18-72 | OR = 1.7 (1.4-1.9)† | OR = 2.3 (2.0-2.6)† | OR = 2.4 (1.8-3.2)† |
N total = 5317 | ||||||
N cases = 2377 | ||||||
FVL | Case-control | The Netherlands | Mean | OR = 1.7 (1.3-2.2) | OR = 4.5 (3.8-5.2) | — |
Van Stralen (2008)3 | N total = 8170 | 48 total | ||||
N cases = 3313 | 49 cases | |||||
De Moerloose (2000)11 | Case-control | Switzerland | 62 (19-99)* | OR = 2.1 (0.68-5.5) | OR = 3.4 (1.5-6.9) | OR = 4.2 (1.5-10.3) |
N total = 748 | ||||||
N cases = 3513 | ||||||
Margaglione (2000)10 | Case-control | Italy | Median, range | OR = 1.5 (0.74-3.1)‡ | OR = 6.3 (4.5-9.0)‡ | OR = 4.4 (2.8-7.0)‡ |
N total = 1976 | 46 (18-86) cases | |||||
N cases = 647 | 37 (22-66) controls | |||||
Manten (1996)4 | Case-control | The Netherlands | Mean | OR = 3.3 (1.0-10.6)† | OR = 6.9 (3.6-12.8)† | — |
N total = 753 | 42 cases | |||||
N cases = 279 | 44 controls | |||||
Martinelli (1997)7 | Case-control | Italy | Median (range) | OR = 1.8 (0.3-9.6)† | OR = 10.0 (4.0-25.5)† | OR = 5.5 (2.0-15.8)† |
N total = 424 | 37 (15-67) total | |||||
N cases = 212 | 35 (15-66) cases | |||||
Baglin (1997)6 | Case-control | United Kingdom | — | OR = 4.8 (2.5-9.2)§ | OR = 8.5 (4.8-14.8)§ | — |
N total = 1189 | ||||||
N cases = 678 | ||||||
Arsov (2006)5 | Case-control | Macedonia | — | OR = 2.6 (0.9-7.6) | OR = 5.3 (2.6-10.8) | — |
N total = 390 | ||||||
N cases = 190 | ||||||
Boyanovsky (2001)9 | Case-control | Bulgaria | Mean (range) | OR = 1.4 (0.45-4.6)‖ | OR = 5.1 (2.0-12.7)‖ | OR = 3.9 (1.5-10.2)‖ |
N total = 228 | 45 (21-68) cases | |||||
N cases = 128 | ||||||
González Ordóñez (2000)8 | Case-control | Spain | Mean (range) | OR = 1.3 (0.3-4.7) | OR = 6.6 (3.1-14.1) | OR = 5.2 (1.3-20.4) |
N total = 584 | 57 (17-93) cases | |||||
N cases = 264 | ||||||
Okumus (2008)68 | Case-control | Turkey | Mean, range | OR = 1.8 (0.82-4.0)¶ | OR = 3.8 (1.6-9.1)¶ | OR = 4.3 (2.1-8.8)¶ |
N total = 382 | 53 (16-88) cases | |||||
N cases = 191 | 51 (16-88) controls | |||||
Prothrombin G20210A | Case-control | The Netherlands | Mean | OR = 2.3 (1.5-3.3) | OR = 3.2 (2.4-4.2) | — |
Van Stralen (2008)3 | N total = 8170 | 48 total | ||||
N cases = 3313 | 49 cases | |||||
Margaglione (2000)10 | Case-control | Italy | Median, range | OR = 2.1 (1.1-4.1)‡ | OR = 3.6 (2.4-5.4)‡ | OR = 3.0 (1.8-5.1)‡ |
N total = 1976 | 46 (18-86) cases | |||||
N cases = 647 | 37 (22-66) controls | |||||
Boyanovsky (2001)9 | Case-control | Bulgaria | Mean (range) | OR = 1.5 (0.41-5.3)‖ | OR = 3.3 (1.1-9.6)‖ | OR = 3.0 (1.0-9.0)‖ |
N total = 228 | 45 (21-68) cases | |||||
N cases = 128 | ||||||
González Ordóñez (2000)8 | Case-control | Spain | Mean (range) | OR = 2.4 (0.9-6.1) | OR = 2.5 (1.1-5.4) | OR = 5.6 (1.6-18.9) |
N total = 584 | 57 (17-93) cases | |||||
N cases = 264 | ||||||
Okumus (2008)68 | Case-control | Turkey | Mean, range | OR = 1.6 (0.45-5.9)¶ | OR = 0.86 (0.10-7.3)¶ | OR = 3.7 (1.3-11.2)¶ |
N total = 382 | 53 (16-88) cases | |||||
N cases = 191 | 51(16-88) controls | |||||
De Moerloose (2000)11 | Case-control | Switzerland | 62 (19-99)* | OR = 0.90 (0.10-3.8) | OR = 0.61 (0.07-2.7) | OR = 2.6 (0.62-8.2) |
N total = 748 | ||||||
N cases = 182 | ||||||
Weischer (2010)69 | Cohort | Denmark | Median, IQR | HR = 1.7 (0.6-4.5)* | HR = 0.8 (0.3-2.5)* | — |
N total = 9231 | 52 (45-57) | |||||
for all VT patients |